RIZVI SYED ALI-AAMIR (Chief Medical Officer) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2024ACC: 0000950170-24-041039
Officer· Chief Medical Officer
Since Apr 2024
+435K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
435K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+185K
Price / share
—
Trade value
—
% of position
New position
4/1/2024
0.00→185K
Total
Net shares
+185K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2024 | A · Award | +185K | — | — | New position | 0.00 | 185K |
| Total | +185K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
3.10
Held after
250K
Exercisable
—
4/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock250K shares | 4/1/2024 | A · Award | +250K | 3.10 | — | 250K |